Supplementary Fig.1 The overall workflow+ S.C. + PMO 10 μM Δ46-55 + S.C. + PMO 5 μM+ PMO 10 μM...

Post on 21-Sep-2020

2 views 0 download

Transcript of Supplementary Fig.1 The overall workflow+ S.C. + PMO 10 μM Δ46-55 + S.C. + PMO 5 μM+ PMO 10 μM...

Supplementary Fig.1 The overall workflow

0-1 1 3 5 13 15 20 40 60Day

Cell plating

7 4~5 days

CHIRActivinA

BMP4 XavMGCHIR

Induced differentiation

PMOEndo-Porter

Exon skipping

RT-PCR, Dystrophin WB, Immunocytochemistry

Ca imaging

E8 RPMI/B27-ins

Single cell replating

RT-PCR

RPMI/B27

Control Patient

OCT4

SOX2

NANOG

β-actin

A B

CDAPI NANOG SSEA-4/DAPIOCT3/4

Supplementary Fig.2 Characterization of established DMD-iPSCs

Neuroepithelium Cartilage Intestine

D

+ S.C. + PMO 10 μM

Δ46-55 + S.C. + PMO 5 μM + PMO 10 μM

500

Supplementary Fig.3 Skipping efficiency of PMO in short and long term culture

A

B

500

1000

1000

690 bp

514 bp

44 45 56 5743

44 56 5743

690 bp

514 bp

44 45 56 5743

44 56 5743

BD FACSDiva 8.0

Global Sheet1 Printed on: 7 9, 2018 06:25:26 JSTPage 1 of 1

Supplementary Fig.4. Flow cytometry for cardiomyocyte differentiation of human iPSCs

BD FACSDiva 8.0

Global Sheet1 Printed on: 7 9, 2018 06:25:36 JSTPage 1 of 1

Cel

l cou

nt

cTnT-PE

Cel

l cou

nt

Isotype IgG-PE